Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone for locally advanced cervical cancer
ChiCTR1900028493Phase 3Recruiting
- Sponsor
- Fourth Affiliated Hospital of Guangxi Medical University
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin + radiotherapy in Cervical Cancer (CC) (2 arms), sponsored by Fourth Affiliated Hospital of Guangxi Medical University. Primary endpoints: overall survival and progression-free survival. Started Jan 2018; status: recruiting.
02
Drugs
cisplatin + radiotherapy
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR1900028493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028493.